Is Revolution Medicines a Good Stock to Own?
Though it’s still quite early in the year, pharmaceutical startup…
Buy
77
MIRM Quote, Financials, Valuation and Earnings
Last price:
$91.09
Seasonality move
:
1.8%
Day range:
$90.86 - $93.70
52-week range:
$36.88 - $93.70
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
9.83x
P/B ratio:
16.02x
Volume:
336.1K
Avg. volume:
846.9K
1-year change:
98.67%
Market cap:
$4.7B
Revenue:
$336.9M
EPS (TTM):
-$0.86
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $19.1M | $77.1M | $186.4M | $336.9M | |
| Revenue Growth (YoY) | -- | -- | 302.67% | 141.85% | 80.76% | |
| Cost of Revenues | $623K | $2.2M | $12.7M | $47.4M | $82.2M | |
| Gross Profit | -$623K | $16.9M | $64.4M | $139M | $254.7M | |
| Gross Profit Margin | -- | 88.31% | 83.5% | 74.58% | 75.61% | |
| R&D Expenses | $81.3M | $131.1M | $106.5M | $102.3M | $140.1M | |
| Selling, General & Admin | $22.7M | $59.2M | $89.1M | $145.9M | $202.2M | |
| Other Inc / (Exp) | -$192K | $106.7M | $1.3M | -$51.9M | $1.2M | |
| Operating Expenses | $103.7M | $190.3M | $195.6M | $248.2M | $342.3M | |
| Operating Income | -$104.3M | -$173.4M | -$131.2M | -$109.2M | -$87.6M | |
| Net Interest Expenses | $335K | $17.6M | $16M | $15.1M | $14.3M | |
| EBT. Incl. Unusual Items | -$103.3M | -$84M | -$142.1M | -$162.4M | -$86.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $6K | $37K | -$6.4M | $991K | $1M | |
| Net Income to Company | -$103.3M | -$84M | -$135.7M | -$163.4M | -$87.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$103.3M | -$84M | -$135.7M | -$163.4M | -$87.9M | |
| Basic EPS (Cont. Ops) | -$4.09 | -$2.77 | -$4.01 | -$4.00 | -$1.85 | |
| Diluted EPS (Cont. Ops) | -$4.09 | -$2.77 | -$4.02 | -$4.00 | -$1.85 | |
| Weighted Average Basic Share | $25.3M | $30.3M | $33.8M | $40.9M | $47.5M | |
| Weighted Average Diluted Share | $25.3M | $30.3M | $33.8M | $40.9M | $47.5M | |
| EBITDA | -$103.7M | -$172.4M | -$127.5M | -$98.3M | -$64M | |
| EBIT | -$104.3M | -$173.4M | -$131.2M | -$109.2M | -$87.6M | |
| Revenue (Reported) | -- | $19.1M | $77.1M | $186.4M | $336.9M | |
| Operating Income (Reported) | -$104.3M | -$173.4M | -$131.2M | -$109.2M | -$87.6M | |
| Operating Income (Adjusted) | -$104.3M | -$173.4M | -$131.2M | -$109.2M | -$87.6M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $5M | $18.8M | $47.7M | $90.4M | $133M | |
| Revenue Growth (YoY) | -- | 275.6% | 154.13% | 89.37% | 47.17% | |
| Cost of Revenues | -- | $3M | $10.3M | $21M | $25.6M | |
| Gross Profit | -- | $15.8M | $37.4M | $69.4M | $107.4M | |
| Gross Profit Margin | -- | 83.88% | 78.44% | 76.81% | 80.75% | |
| R&D Expenses | $30.4M | $26.1M | $26.1M | $31.6M | $42.9M | |
| Selling, General & Admin | $17.4M | $22.5M | $36.5M | $50.5M | $61.9M | |
| Other Inc / (Exp) | $1.3M | -$192K | $1.3M | -$1.1M | -- | |
| Operating Expenses | $42.8M | $48.6M | $62.6M | $82.1M | $104.8M | |
| Operating Income | -$42.8M | -$32.9M | -$25.1M | -$12.7M | $2.6M | |
| Net Interest Expenses | $5.7M | $4M | $3.6M | $3.6M | $3.6M | |
| EBT. Incl. Unusual Items | -$47.1M | -$35.7M | -$23.3M | -$13.9M | $2.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $9K | $13K | $249K | $347K | -$262K | |
| Net Income to Company | -$47.1M | -$35.7M | -$23.6M | -$14.2M | $2.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$47.1M | -$35.7M | -$23.6M | -$14.2M | $2.9M | |
| Basic EPS (Cont. Ops) | -$1.55 | -$1.02 | -$0.57 | -$0.30 | $0.06 | |
| Diluted EPS (Cont. Ops) | -$1.55 | -$1.02 | -$0.57 | -$0.30 | $0.05 | |
| Weighted Average Basic Share | $30.4M | $34.9M | $41.1M | $47.8M | $50.6M | |
| Weighted Average Diluted Share | $30.4M | $34.9M | $41.1M | $47.8M | $57M | |
| EBITDA | -$42.6M | -$31.7M | -$22.5M | -$6.6M | $8.7M | |
| EBIT | -$42.8M | -$32.9M | -$25.1M | -$12.7M | $2.6M | |
| Revenue (Reported) | $5M | $18.8M | $47.7M | $90.4M | $133M | |
| Operating Income (Reported) | -$42.8M | -$32.9M | -$25.1M | -$12.7M | $2.6M | |
| Operating Income (Adjusted) | -$42.8M | -$32.9M | -$25.1M | -$12.7M | $2.6M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $16M | $52.3M | $144.7M | $307M | $471.8M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | $10.1M | $26.7M | $81.9M | $95.1M | |
| Gross Profit | -$350K | $42.2M | $118M | $225.1M | $376.7M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $133M | $103.2M | $102.5M | $127M | $178.8M | |
| Selling, General & Admin | $47.4M | $81.6M | $126.2M | $191.6M | $239.7M | |
| Other Inc / (Exp) | -$231K | $108M | -$48.8M | -$2.1M | -- | |
| Operating Expenses | $164.4M | $184.8M | $228.7M | $318.5M | $418.5M | |
| Operating Income | -$164.8M | -$142.6M | -$110.7M | -$93.5M | -$41.8M | |
| Net Interest Expenses | $14.2M | $15.4M | $15.9M | $14.3M | $14.4M | |
| EBT. Incl. Unusual Items | -$178.7M | -$48.2M | -$163.3M | -$95.5M | -$40.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $27K | -$6.5M | $906K | $1.8M | $593K | |
| Net Income to Company | -$178.7M | -$41.7M | -$164.2M | -$99.8M | -$41.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$178.7M | -$41.7M | -$164.2M | -$97.3M | -$41.4M | |
| Basic EPS (Cont. Ops) | -$6.10 | -$1.15 | -$4.30 | -$2.07 | -$0.86 | |
| Diluted EPS (Cont. Ops) | -$6.10 | -$1.15 | -$4.31 | -$2.07 | -$0.86 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$164.1M | -$139.8M | -$103.8M | -$70.5M | -$17.6M | |
| EBIT | -$164.8M | -$142.6M | -$110.7M | -$93.5M | -$41.8M | |
| Revenue (Reported) | $16M | $52.3M | $144.7M | $307M | $471.8M | |
| Operating Income (Reported) | -$164.8M | -$142.6M | -$110.7M | -$93.5M | -$41.8M | |
| Operating Income (Adjusted) | -$164.8M | -$142.6M | -$110.7M | -$93.5M | -$41.8M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $16M | $49.2M | $116.8M | $237.5M | $372.4M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $185K | $8.1M | $22.2M | $59.3M | $72.2M | |
| Gross Profit | -$185K | $41M | $94.7M | $178.1M | $300.1M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $103.4M | $75.5M | $71.5M | $96.1M | $134.8M | |
| Selling, General & Admin | $40.2M | $62.6M | $99.7M | $145.4M | $182.9M | |
| Other Inc / (Exp) | -$148K | $1.2M | -$48.8M | $982K | $2.2M | |
| Operating Expenses | $127.7M | $138.1M | $171.2M | $241.5M | $317.7M | |
| Operating Income | -$127.8M | -$97.1M | -$76.6M | -$63.4M | -$17.6M | |
| Net Interest Expenses | $13.8M | $11.6M | $11.5M | $10.7M | $10.8M | |
| EBT. Incl. Unusual Items | -$141.5M | -$105.8M | -$127M | -$62.5M | -$16.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $25K | -$6.5M | $766K | $1.6M | $1.2M | |
| Net Income to Company | -$141.5M | -$99.2M | -$127.8M | -$64.2M | -$17.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$141.5M | -$99.2M | -$127.8M | -$64.2M | -$17.6M | |
| Basic EPS (Cont. Ops) | -$4.68 | -$3.03 | -$3.32 | -$1.36 | -$0.36 | |
| Diluted EPS (Cont. Ops) | -$4.68 | -$3.03 | -$3.32 | -$1.36 | -$0.37 | |
| Weighted Average Basic Share | $90.7M | $98.4M | $116.9M | $141.9M | $149.3M | |
| Weighted Average Diluted Share | $90.7M | $98.4M | $116.9M | $141.9M | $155.6M | |
| EBITDA | -$127.3M | -$94.7M | -$70.9M | -$45.8M | $601K | |
| EBIT | -$127.8M | -$97.1M | -$76.6M | -$63.4M | -$17.6M | |
| Revenue (Reported) | $16M | $49.2M | $116.8M | $237.5M | $372.4M | |
| Operating Income (Reported) | -$127.8M | -$97.1M | -$76.6M | -$63.4M | -$17.6M | |
| Operating Income (Adjusted) | -$127.8M | -$97.1M | -$76.6M | -$63.4M | -$17.6M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $231.8M | $156.5M | $151.7M | $286.3M | $280.3M | |
| Short Term Investments | $89.7M | $125.2M | $123.7M | -- | $57.8M | |
| Accounts Receivable, Net | -- | $3.3M | $23.8M | $68M | $78.3M | |
| Inventory | -- | $1.5M | $5.6M | $22.3M | $22.4M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $4.5M | $5.3M | $8.9M | $10.9M | $11.8M | |
| Total Current Assets | $236.4M | $166.6M | $190.2M | $387.5M | $392.8M | |
| Property Plant And Equipment | $3.2M | $2.6M | $2.3M | $2M | $9.8M | |
| Long-Term Investments | -- | $105M | $100M | -- | $13M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | $18.7M | -- | $252.9M | $249.8M | |
| Other Long-Term Assets | $1.3M | $101.8M | $101.4M | $4.2M | $5.8M | |
| Total Assets | $240.9M | $294.7M | $352.9M | $646.6M | $670.8M | |
| Accounts Payable | $3.2M | $9.2M | $8.7M | $7.4M | $14.6M | |
| Accrued Expenses | $8.6M | $20.1M | $36.9M | $50.9M | $68.6M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $636K | $711K | $931K | $1.1M | $1.7M | |
| Other Current Liabilities | $1.3M | $2M | $1.1M | -- | -- | |
| Total Current Liabilities | $18.5M | $42.6M | $64.7M | $87.1M | $126.6M | |
| Long-Term Debt | $50.3M | $131.8M | $141.6M | $307M | $316.1M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $68.8M | $174.4M | $210.9M | $398M | $445.1M | |
| Common Stock | $3K | $3K | $4K | $5K | $5K | |
| Other Common Equity Adj | $83K | -$35K | -$217K | $1.6M | -$373K | |
| Common Equity | $172.1M | $120.2M | $142M | $248.7M | $225.6M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $172.1M | $120.2M | $142M | $248.7M | $225.6M | |
| Total Liabilities and Equity | $240.9M | $294.7M | $352.9M | $646.6M | $670.8M | |
| Cash and Short Terms | $231.8M | $156.5M | $151.7M | $286.3M | $280.3M | |
| Total Debt | $50.3M | $131.8M | $141.6M | $307M | $316.1M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $190M | $185.3M | $306M | $284.4M | $375.5M | |
| Short Term Investments | $134.2M | $149.6M | $3M | $61.5M | -- | |
| Accounts Receivable, Net | -- | $16.3M | $45.4M | $68.5M | $107.1M | |
| Inventory | -- | $6.9M | $22.3M | $21.6M | $24M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $6.4M | $6.9M | $12.5M | $12.1M | -- | |
| Total Current Assets | $196.8M | $215.6M | $388.6M | $386.6M | $530.6M | |
| Property Plant And Equipment | $2.7M | $2M | $2.2M | $10.3M | $9.8M | |
| Long-Term Investments | $15M | $100M | -- | $9.7M | $3M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | $45M | $258.3M | $255.8M | -- | |
| Other Long-Term Assets | $1.6M | $101.7M | $1.5M | $5.8M | -- | |
| Total Assets | $235.2M | $364.3M | $650.6M | $667.9M | $785.1M | |
| Accounts Payable | $5M | $10.5M | $7.4M | $9.5M | $12.2M | |
| Accrued Expenses | $37.1M | $21.3M | $33.6M | $73M | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $690K | $775K | $1.1M | $1.5M | -- | |
| Other Current Liabilities | $847K | $1.8M | -- | -- | -- | |
| Total Current Liabilities | $50.4M | $51.4M | $74.7M | $115.8M | $160.4M | |
| Long-Term Debt | $128.4M | $139.3M | $306.9M | $316.1M | $316.7M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $178.8M | $195.1M | $381.6M | $435.9M | $493.1M | |
| Common Stock | $3K | $4K | $5K | $5K | $5K | |
| Other Common Equity Adj | -$6K | -$413K | -$1.5M | $920K | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $56.4M | $169.3M | $269.1M | $232M | $292M | |
| Total Liabilities and Equity | $235.2M | $364.3M | $650.6M | $667.9M | $785.1M | |
| Cash and Short Terms | $190M | $185.3M | $306M | $284.4M | $375.5M | |
| Total Debt | $128.4M | $139.3M | $306.9M | $316.1M | $316.7M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$103.3M | -$84M | -$135.7M | -$163.4M | -$87.9M | |
| Depreciation & Amoritzation | $623K | $975K | $3.7M | $10.8M | $23.6M | |
| Stock-Based Compensation | $12.6M | $23.1M | $27M | $35M | $48.4M | |
| Change in Accounts Receivable | -- | -- | -$20.7M | -$44M | -$11.4M | |
| Change in Inventories | -- | -$495K | -$3.4M | -$4.4M | -$3.2M | |
| Cash From Operations | -$89.1M | -$132.8M | -$120.1M | -$70.9M | $10.3M | |
| Capital Expenditures | $225K | $19M | $278K | $20.1M | $21M | |
| Cash Acquisitions | -- | -- | -- | $212.8M | -- | |
| Cash From Investing | $37.9M | $48.5M | $7.7M | -$107.2M | -$90.1M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | $305.3M | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $49.4M | $64.5M | -$5.6M | -$195.9M | -- | |
| Cash From Financing | $181.3M | $73.5M | $109.1M | $336.6M | $17.7M | |
| Beginning Cash (CF) | $142.1M | $31.3M | $28M | $286.3M | $222.5M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $130.1M | -$10.7M | -$3.3M | $158.3M | -$63.4M | |
| Ending Cash (CF) | $272.2M | $20.6M | $24.7M | $444.5M | $157.8M | |
| Levered Free Cash Flow | -$89.3M | -$151.8M | -$120.4M | -$91.1M | -$10.7M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$47.1M | -$35.7M | -$23.6M | -$14.2M | $2.9M | |
| Depreciation & Amoritzation | $178K | $1.2M | $2.4M | $6.1M | $6.1M | |
| Stock-Based Compensation | $7.4M | $6.7M | $8.4M | $11.9M | $18.1M | |
| Change in Accounts Receivable | -- | -$2.3M | -$12.5M | -$8.1M | -$3.1M | |
| Change in Inventories | -- | -$2.8M | -$439K | $3.7M | -$1.2M | |
| Cash From Operations | -$34.2M | -$26M | -$18.2M | $4M | $39.7M | |
| Capital Expenditures | $18K | $19K | -- | $10.2M | $187K | |
| Cash Acquisitions | -- | -- | $212.8M | -- | -- | |
| Cash From Investing | -$2.2M | -$79.5M | -$182.8M | -$18M | -$2.2M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$1.7M | -- | -- | -- | |
| Cash From Financing | $345K | $86.1M | $207.1M | $3.9M | $16.1M | |
| Beginning Cash (CF) | $55.8M | $35.8M | $303.1M | $223M | $282M | |
| Foreign Exchange Rate Adjustment | -- | -$21K | -$315K | $88K | $349K | |
| Additions / Reductions | -$36.1M | -$19.5M | $5.8M | -$10.1M | $53.9M | |
| Ending Cash (CF) | $19.8M | $16.2M | $308.6M | $213M | $336.3M | |
| Levered Free Cash Flow | -$34.2M | -$26M | -$18.2M | -$6.2M | $39.5M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$178.7M | -$41.7M | -$164.2M | -$99.8M | -$41.4M | |
| Depreciation & Amoritzation | $703K | $2.8M | $6.7M | $23.1M | $24.2M | |
| Stock-Based Compensation | $21.1M | $25.7M | $32.2M | $44.9M | $65.6M | |
| Change in Accounts Receivable | -- | -$13.1M | -$31.5M | -$20.7M | -$39.9M | |
| Change in Inventories | -- | -$4.5M | -$1.6M | -$5.1M | -$6.4M | |
| Cash From Operations | -$135.9M | -$119M | -$88.6M | -$1.2M | $44.7M | |
| Capital Expenditures | $49K | $19M | $15.4M | $26M | $374K | |
| Cash Acquisitions | -- | -- | $212.8M | -- | -- | |
| Cash From Investing | -$64.4M | $89M | -$78.4M | -$92.8M | -$24.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $114.2M | -- | -- | -- | -- | |
| Cash From Financing | $207.4M | $110M | $334.5M | $14.1M | $36.5M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $7.1M | $79.9M | $167.3M | -$79.7M | $59.1M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$135.9M | -$138.1M | -$103.9M | -$27.2M | $44.3M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$141.5M | -$99.2M | -$127.8M | -$64.2M | -$17.6M | |
| Depreciation & Amoritzation | $538K | $2.4M | $5.3M | $17.6M | $18.2M | |
| Stock-Based Compensation | $17.5M | $20.1M | $25.3M | $35.2M | $52.4M | |
| Change in Accounts Receivable | -- | -$13.1M | -$23.8M | -$562K | -$29M | |
| Change in Inventories | -- | -$4M | -$2.2M | -$3M | -$6.2M | |
| Cash From Operations | -$99.6M | -$85.9M | -$54.3M | $15.4M | $49.8M | |
| Capital Expenditures | $21K | $36K | $15.1M | $21M | $354K | |
| Cash Acquisitions | -- | -- | $212.8M | -- | -- | |
| Cash From Investing | -$59.5M | -$19.1M | -$105.2M | -$90.8M | -$25M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | $305.3M | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $64.6M | -$3.5M | -$195.6M | -- | -- | |
| Cash From Financing | $72.9M | $109.4M | $334.8M | $12.4M | $31.1M | |
| Beginning Cash (CF) | $238.5M | $137.3M | $649.7M | $759.1M | $722M | |
| Foreign Exchange Rate Adjustment | -$6K | -$73K | -$241K | $82K | $3.6M | |
| Additions / Reductions | -$86.2M | $4.4M | $175.1M | -$62.9M | $59.6M | |
| Ending Cash (CF) | $152.2M | $141.6M | $824.5M | $696.2M | $785.2M | |
| Levered Free Cash Flow | -$99.6M | -$85.9M | -$69.4M | -$5.6M | $49.4M | |
Get MIRM Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
MIRM
Sector
P/E ratio
--
23.89x
PEG ratio
-2.19x
-0.01x
P/B ratio
16.02x
1.81x
Price / LTM sales
9.83x
1.59x
Growth Metrics
MIRM
Sector
Revenue growth
47.17%
4.35%
Earnings growth
117.12%
9.8%
Revenue (5-year growth)
--
6.41%
Earnings forecast
-$0.04
-$0.18
Profitability
MIRM
Sector
Profitability FY 2024
$254.7M
$3.2M
Return on invested capital
-7.32%
-32.76%
Return on assets
-5.85%
-29.32%
Return on equity
-16.73%
-38.6%
Earnings Date
Last Earnings Date
Nov
4
Next Earnings Date
Feb
25
Estimated Next Earnings Date
Feb
3
Balance Sheet
MIRM
Sector
Total cash
$375.5M
$25.4M
Short term investments
$57.8M
$25.1M
Total assets
$670.8M
$74.7M
Long term debt
$316.7M
$3.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Has Vistra Stock Gone Up?
Integrated power generation business Vistra (NYSE:VST) surprised investors recently when…
Why Is Amkor Stock Up So Much?
Semiconductor packaging and testing major Amkor (NASDAQ:AMKR) has started 2026…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Sell
48
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
75
AGX alert for Jan 17
Argan, Inc. [AGX] is up 16.4% over the past day.
Buy
80
ASTS alert for Jan 17
AST Spacemobile, Inc. [ASTS] is up 14.32% over the past day.
Buy
84
IREN alert for Jan 17
IREN Ltd. [IREN] is up 11.35% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
